Logo
ISO 9001:2000
Menu Arrow
Menu Top
Menu Arrow
Menu Top
Menu Arrow
ISO Certified

Medicare Information Resource

Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material which is copyrighted by the American Medical Association (AMA). You are forbidden to download the files unless you read, agree to and abide by the provisions of the copyright statement. Read the copyright statement now (you will be linked back to here).

Medicare Information Resource Part A and B Combined
MIR-2006-6AB, June 2006

MLN Matters. . .Information for Medicare Providers
(Issued by the Centers for Medicare & Medicaid Services)

Bariatric Surgery for Morbid Obesity

Provider Types Affected
Physicians, suppliers, and providers billing Medicare carriers and/or fiscal intermediaries (FIs) for services related to bariatric surgery

Provider Action Needed

Impact to You
This article is based on Change Request (CR) 5013, which modifies the Medicare National Coverage Determination Manual (NCDM, Sections 40.5 and 100.1) and adds section 150 to Chapter 32 of the Medicare Claims Processing Manual to be consistent with the new Centers for Medicare & Medicaid Services (CMS) policy for bariatric surgery.

What You Need to Know
Effective for services on or after February 21, 2006, Medicare will cover open and laparoscopic Roux-en-Y gastric bypass (RYGBP), laparoscopic adjustable gastric banding (LAGB) and open and laparoscopic biliopancreatic diversion with duodenal switch (BPD/DS) if certain criteria are met and the procedure is performed in an approved facility.

In addition, effective for services performed on or after February 21, 2006, Medicare has decided that open vertical banded gastroplasty, laparoscopic vertical banded gastroplasty, open sleeve gastrectomy, laparoscopic sleeve gastrectomy, and open adjustable gastric banding are nationally noncovered for Medicare.

What You Need to Do
See the Background section of this article for further details regarding these changes.

Background
Bariatrics is the branch of medicine dealing with obesity, and bariatric surgery can be an effective treatment for patients who have been unsuccessful with diet and exercise and have comorbid conditions such as:

  • Coronary artery disease;
  • Diabetes; and
  • Sleep apnea.

Bariatric surgery procedures are performed to treat many comorbid conditions associated with obesity, and two types of surgical procedures are employed:

  • Malabsorptive surgical procedures divert food from the stomach to a lower part of the digestive tract where the normal mixing of digestive fluids and adsorption of nutrients cannot occur; and
  • Restrictive surgical procedures restrict the size of the stomach and decrease intake.

Some surgeries combine both of these types of procedures, and brief descriptions of bariatric surgery procedures are included in the Additional Information section of this article. Also, see the Medicare National Coverage Determinations Manual (Pub. 100-03, Chapter 1, Part 2, Section 100.1 (Bariatric Surgery for Morbid Obesity (Effective February 21, 2006), Subsection A (General)), attached to CR5013.

Note: Bariatric surgery is recommended only for individuals with health concerns related to their obesity.

CMS has determined the evidence is adequate to conclude that:

  • If a Medicare beneficiary has documented in their medical record that they:
  • Have a body-mass index (BMI) ≥ 35, with at least one co-morbidity related to obesity; and
  • Have been previously unsuccessful with medical treatment for obesity;
  • Then the following procedures (performed on or after February 21, 2006) are considered reasonable and necessary:
  • Open and laparoscopic Roux-en-Y gastric bypass (RYGBP);
  • Laparoscopic adjustable gastric banding (LAGB); and
  • Open and laparoscopic biliopancreatic diversion (BPD) with duodenal switch (DS).

 
Approved Facilities
In addition, CMS has determined that covered bariatric surgery procedures are reasonable and necessary only when performed at facilities certified by:

  • The American College of Surgeons ((ACS) http://www.facs.org/cqi/bscn/ External link  )) as a Level 1 Bariatric Surgery Center (BSC; program standards and requirements in effect on February 15, 2006); or
  • The American Society for Bariatric Surgery ((ASBS) http://www.asbs.org/ External link  )) as a Bariatric Surgery Center of Excellence (BSCOE; program standards and requirements in effect on February 15, 2006).

A list of approved facilities and their approval dates will be listed and maintained on the CMS coverage Web site at http://www.cms.hhs.gov/MedicareApprovedFacilitie/BSF/list.asp#TopOfPage External link  . This information will also be published in the Federal Register.

When services are performed in an unapproved facility, Medicare will deny the claim with a claim reason adjustment code of 58 (Payment adjusted because treatment was deemed by the payer to have been rendered in an inappropriate or invalid place of service).

For providers to avoid liability for charges when services are performed in an unapproved facility, physicians must have the beneficiary sign an Advance Beneficiary Notice (ABN), and hospitals, including critical access hospitals, must have the beneficiary sign a Hospital Issued Notice of Noncoverage (HINN).

 
Noncovered Procedures
The evidence is not adequate to conclude that the following bariatric surgery procedures are reasonable and necessary; therefore, the following procedures are noncovered for all Medicare beneficiaries:

  • Open vertical banded gastroplasty
  • Laparoscopic vertical banded gastroplasty
  • Open sleeve gastrectomy
  • Laparoscopic sleeve gastrectomy
  • Open adjustable gastric banding

 
Changes in Manuals
The Medicare Claims Processing Manual (Pub.100-04, Chapter 32 (Billing Requirements for Special Services), Section 150 (Billing Requirements for Bariatric Surgery for Morbid Obesity)) is being added to reflect the new coverage for bariatric surgery.

In addition, the Medicare National Coverage Determination Manual (NCDM, Pub. 100-03, Chapter I, Sections 40.5 and 100.1) are being modified to be consistent with the new CMS policy for bariatric surgery. These revisions are attached to CR5013.

The revision of the NCDM will include a reference to the covered surgical procedures, and revise the obesity policy with the final bariatric surgery policy. The modified obesity policy will read as follows (changes bolded and italicized):

“Obesity may be caused by medical conditions such as hypothyroidism, Cushing’s disease, and hypothalamic lesions or can aggravate a number of cardiac and respiratory diseases as well as diabetes and hypertension. Non-surgical services in connection with the treatment of obesity are covered when such services are an integral and necessary part of a course of treatment for one of these medical conditions. Certain designated surgical services for the treatment of obesity are covered for Medicare beneficiaries who have a BMI ≥ 35, have at least one co-morbidity related to obesity and have been previously unsuccessful with the medical treatment of obesity.”

Treatments for obesity alone remain noncovered, and the following noncoverage determinations in the National Coverage Determination Manual (NCDM, Chapter 1, Part 2; http://www.cms.hhs.gov/manuals/downloads/ncd103c1_Part2.pdf External pdf file   ) remain unchanged:

  • Section 100.8 (Intestinal Bypass Surgery); and
  • Section 100.11 (Gastric Balloon for Treatment of Obesity).

 
Additional Instructions
CR5013 further instructs your carrier and/or fiscal intermediary to:

  • Accept the following Healthcare Common Procedure Coding System (HCPCS) as of February 21, 2006:
  • 43770 - Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric band (gastric band and subcutaneous port components)
  • 43644 - Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less)
  • 43645 - Laparoscopy with gastric bypass and small intestine reconstruction to limit absorption. (Do not report 43645 in conjunction with 49320, 43847.)
  • 43845 - Gastric restrictive procedure with partial gastrectomy, pylorus- preserving duodenoileostomy and ileoieostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch)
  • 43846 - Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less Roux-en-Y gastroenterostomy. ( For greater than 150 cm, use 43847)( For laparoscopic procedure, use 43644)
  • 43847 - With small intestine reconstruction to limit absorption;
  • Accept HCPCS codes 43770, 43644, 43645, 43845, 43846, and 43847 submitted with at least one of the following diagnosis codes: V85.35; V85.36; V85.37; V85.38; V85.39; V85.4; or 278.01. (Claims will be denied without an appropriate diagnosis code.);
  • Accept International Classification of Diseases, Ninth Revision (ICD-9) procedure codes 44.38, 44.39, 44.95, 43.89, 45.51, and 45.91, when the following diagnosis codes are reported: V85.35; V85.36; V85.37; V85.38; V85.39; V85.4; and 278.01. (Claims will be denied without an appropriate diagnosis code and none of the V diagnosis codes for BMI ≥ 35 or 278.01 for morbid obesity can be the principal diagnosis on an inpatient Medicare claim); and
  • Accept the following ICD-9 Procedure Codes as of February 21, 2006:
  • 44.38 - Laparoscopic gastroenterostomy (laparoscopic Roux-en-Y);
  • 44.39 - Other Gastroenterostomy (open Roux-en-Y); and
  • 44.95 - Laparoscopic gastric restrictive procedure (laparoscopic adjustable gastric band and port insertion).

Important Note: There is not a distinction between laparoscopic and open biliopancreatic diversion (BPD) with duodenal switch (DS) for the inpatient setting. The codes would apply to the open approach as follows:

  • 43.89 Other partial gastrectomy;
  • 45.51 Isolation of segment of small intestine; and
  • 45.91 Small to small intestinal anastomosis.

Should claims be denied for failure to have the appropriate diagnosis code, the carrier/FI will use claim adjustment reason code #167 to denote “This/these diagnosis(es) is (are) not covered.”

Note that 44.68 (Laparoscopic gastroplasty (vertical banded gastroplasty)) is noncovered for Medicare effective February 21, 2006.

Additional Fiscal Intermediary Billing Requirements
The FI will pay for Bariatric Surgery only when the services are submitted on type of bill (TOB) of 11X.

The type of facility and setting determines the basis of payment:

  • For services performed in inpatient hospitals, TOB 11X, IPPS payment is based on the DRG.
  • For services performed in CAH inpatient hospitals, TOB 11X, on 101 percent of facility specific per visit rate.
  • For services performed in IHS inpatient hospitals TOB 11X under IPPS based DRG.
  • For services performed in IHS critical access hospitals, TOB 11X, under 101 percent facility specific per diem rate.

Implementation
The implementation date for CR 5013 is May 30, 2006 for physician claims billed to Medicare carriers and October 2, 2006 for hospital claims billed to FIs.

Additional Information
For complete details, please see the official instruction, CR5013, issued to your carrier/intermediary regarding this change. There will be two parts to this CR, one for the NCD and one for the claims processing instruction. The NCD, which includes descriptions of the Bariatric Surgery procedures, is at http://www.cms.hhs.gov/Transmittals/downloads/R54NCD.pdf External P D F and the claims processing instruction may be viewed at http://www.cms.hhs.gov/Transmittals/downloads/R931CP.pdf External P D F on the CMS Web site.

If you have any questions, please contact your carrier/intermediary at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.pdf External P D F on the CMS Web site.

Disclaimer
This article was prepared as a service to the public and is not intended to grant rights or impose obligations. This article may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations and other interpretive materials for a full and accurate statement of their contents.

MLN Matters Number: MM5013
Related Change Request (CR) #: 5013
Related CR Release Date: April 28, 2006
Effective Date: February 21, 2006
Related CR Transmittal #: R931CP and R54NCD
Implementation Date: May 30, 2006 for physician claims billed to carriers, and October 2, 2006, for hospital claims billed to FIs

Additional Information Provided by Empire Medicare Services for Part B ONLY
Empire Medicare Services has specifically defined a listing of co-morbid conditions which meet the primary diagnosis requirements. The listing can be found in our Local Coverage Determinations L13917 (NJ) and L13918 (NY).

Primary Diagnosis Codes

250.00

Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled

250.01

Diabetes mellitus without mention of complication, type I (juvenile type), not stated as uncontrolled

250.02

Diabetes mellitus without mention of complication, type II or unspecified type, uncontrolled

250.03

Diabetes mellitus without mention of complication, type I (juvenile type), uncontrolled

250.10

Diabetes with ketoacidosis, type II or unspecified type, not stated as uncontrolled

250.11

Diabetes with ketoacidosis, type I (juvenile type), not stated as uncontrolled

250.12

Diabetes with ketoacidosis, type II or unspecified, uncontrolled

250.13

Diabetes with ketoacidosis, type I (juvenile type), uncontrolled

250.20

Diabetes with hyperosmolarity, type II or unspecified type, not stated as uncontrolled

250.21

Diabetes with hyperosmolarity, type I (juvenile type), not stated as uncontrolled

250.22

Diabetes with hyperosmolarity, type II or unspecified type, uncontrolled

250.23

Diabetes with hyperosmolarity, type I (juvenile type), uncontrolled

250.30

Diabetes with other coma, type II or unspecified, not stated as uncontrolled

250.31

Diabetes with other coma, type I (juvenile type), not stated as uncontrolled

250.32

Diabetes with other coma, type II or unspecified type, uncontrolled

250.33

Diabetes with other coma, type I (juvenile type), uncontrolled

250.40

Diabetes with renal manifestations, type II or unspecified type, not stated as uncontrolled

250.41

Diabetes with renal manifestations, type I (juvenile type), not stated as uncontrolled

250.42

Diabetes with renal manifestations, type II or unspecified type, uncontrolled

250.43

Diabetes with renal manifestations, type I (juvenile type), uncontrolled

250.50

Diabetes with ophthalmic manifestations, type II or unspecified type, not stated as uncontrolled

250.51

Diabetes with ophthalmic manifestations, type I (juvenile type), not stated as uncontrolled

250.52

Diabetes with ophthalmic manifestations, type II or unspecified type, uncontrolled

250.53

Diabetes with ophthalmic manifestations, type I (juvenile type), uncontrolled

250.60

Diabetes with neurological manifestations, type II or unspecified type, not stated as uncontrolled

250.61

Diabetes with neurological manifestations, type I (juvenile type), not stated as uncontrolled

250.62

Diabetes with neurological manifestations, type II or unspecified type, uncontrolled

250.63

Diabetes with neurological manifestations, type I (juvenile type), uncontrolled

250.70

Diabetes with peripheral circulatory disorders, type II or unspecified type, not stated as uncontrolled

250.71

Diabetes with peripheral circulatory disorders, type I (juvenile type), not stated as uncontrolled

250.72

Diabetes with peripheral circulatory disorders, type II or unspecified type, uncontrolled

250.73

Diabetes with peripheral circulatory disorders, type I (juvenile type), uncontrolled

250.80

Diabetes with other specified manifestations, type II or unspecified type, not stated as uncontrolled

250.81

Diabetes with other specified manifestations, type I (juvenile type), not stated as uncontrolled

250.82

Diabetes with other specified manifestations, type II or unspecified type, uncontrolled

250.83

Diabetes with other specified manifestations, type I (juvenile type), uncontrolled

250.90

Diabetes with unspecified complication, type II or unspecified type, not stated as uncontrolled

250.91

Diabetes with unspecified complication, type I (juvenile type), not stated as uncontrolled

250.92

Diabetes with unspecified complication, type II or unspecified type, uncontrolled

250.93

Diabetes with unspecified complication, type I (juvenile type), uncontrolled

327.20

Organic sleep apnea, unspecified

327.23

Obstructive sleep apnea (adult)(pediatric)

327.26

Sleep related hypoventilation/hypoxemia in conditions classifiable elsewhere

327.27

Central sleep apnea in conditions classified elsewhere

327.29

Other organic sleep apnea

401.0

Malignant essential hypertension

401.1

Benign essential hypertension

401.9

Unspecified essential hypertension

402.00

Malignant hypertensive heart disease without heart failure

402.01

Malignant hypertensive heart disease with heart failure

402.10

Benign hypertensive heart disease without heart failure

402.11

Benign hypertensive heart disease with heart failure

402.90

Unspecified hypertensive heart disease without heart failure

402.91

Unspecified hypertensive heart disease with heart failure

403.00

Malignant hypertensive kidney disease without chronic kidney disease

403.01

Malignant hypertensive kidney disease with chronic kidney disease

403.10

Benign hypertensive kidney disease without chronic kidney disease

403.11

Benign hypertensive kidney disease with chronic kidney disease

403.90

Unspecified hypertensive kidney disease without chronic kidney disease

403.91

Unspecified hypertensive kidney disease with chronic kidney disease

404.00

Malignant hypertensive heart and kidney disease without heart failure or chronic kidney disease

404.01

Malignant hypertensive heart and kidney disease with heart failure

404.02

Malignant hypertensive heart and kidney disease with chronic kidney disease

404.03

Malignant hypertensive heart and kidney disease with heart failure and chronic kidney disease

404.10

Benign hypertensive heart and kidney disease without heart failure or chronic kidney disease

404.11

Benign hypertensive heart and kidney disease with heart failure

404.12

Benign hypertensive heart and kidney disease with chronic kidney disease

404.13

Benign hypertensive heart and kidney disease with heart failure and chronic kidney disease

404.90

Unspecified hypertensive heart and kidney disease without heart failure or chronic kidney disease

404.91

Unspecified hypertensive heart and kidney disease with heart failure

404.92

Unspecified hypertensive heart and kidney disease with chronic kidney disease

404.93

Unspecified hypertensive heart and kidney disease with heart failure and chronic kidney disease

405.01

Malignant secondary hypertension, renovascular

405.09

Malignant secondary hypertension, other

405.11

Benign secondary hypertension, renovascular

405.19

Benign secondary hypertension, other

405.91

Unspecified secondary hypertension, renovascular

405.99

Unspecified secondary hypertension, other

414.00

Coronary atherosclerosis of unspecified type of vessel, native or graft

414.01

Coronary atherosclerosis of native coronary artery

414.02

Coronary atherosclerosis of autologous vein bypass graft

414.03

Coronary atherosclerosis of nonautologous biological bypass graft

414.04

Coronary atherosclerosis of artery bypass graft

414.05

Coronary atherosclerosis of unspecified type of bypass

416.9

Chronic pulmonary heart disease, unspecified

425.4

Other primary cardiomyopathies

425.9

Secondary cardiomyopathy, unspecified

428.0

Congestive heart failure, unspecified

428.9

Heart failure, unspecified

492.0

Emphysematous bleb

492.8

Other emphysema

493.00

Extrinsic asthma without mention of status asthmaticus or acute exacerbation or unspecified

493.01

Extrinsic asthma with status asthmaticus

493.02

Extrinsic asthma with acute asthmaticus

493.10

Intrinsic asthma without mention of status asthmaticus or acute exacerbation or unspecified

493.11

Intrinsic asthma with status asthmaticus

493.12

Intrinsic asthma with acute asthmaticus

493.20

Chronic obstructive asthma without mention of status asthmaticus or acute exacerbation or unspecified

493.21

Chronic obstructive asthma with status asthmaticus

493.22

Chronic obstructive asthma with acute asthmaticus

493.90

Asthma, unspecified without mention of status asthmaticus or acute exacerbation or unspecified

493.91

Asthma, unspecified with status asthmaticus

493.92

Asthma, unspecified with acute asthmaticus

494.0

Bronchiectasis without acute exacerbation

494.1

Bronchiectasis with acute exacerbation

496

Chronic airway obstruction, not elsewhere classified

530.11

Reflux esophagitis

530.19

Other esophagitis

715.09

Osteoarthrosis, generalized, multiple sites

715.15

Osteoarthrosis, localized, primary, pelvic region and thigh

715.16

Osteoarthrosis, localized, primary, lower leg

715.25

Osteoarthrosis, localized, secondary, pelvic region and thigh

715.26

Osteoarthrosis, localized, secondary, lower leg

715.35

Osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh

715.36

Osteoarthrosis, localized, not specified whether primary or secondary, lower leg

715.89

Osteoarthrosis, involving, or with mention of more than one site, but not specified as generalized, multiple sites

715.95

Osteoarthrosis, localized, not specified whether primary or secondary pelvic region and thigh

715.96

Osteoarthrosis, localized, not specified whether primary or secondary, lower leg

780.51

Insomnia with sleep apnea, unspecified

780.57

Unspecified sleep apnea

 

   
 
Spacer Image
 Translate this page >> 
 
 
 
 
 
 
 
 
 
 
Copyright